KR960037679A - 신규한 시스-튜불라졸 유도체 및 그의 제조방법 - Google Patents

신규한 시스-튜불라졸 유도체 및 그의 제조방법 Download PDF

Info

Publication number
KR960037679A
KR960037679A KR1019950009470A KR19950009470A KR960037679A KR 960037679 A KR960037679 A KR 960037679A KR 1019950009470 A KR1019950009470 A KR 1019950009470A KR 19950009470 A KR19950009470 A KR 19950009470A KR 960037679 A KR960037679 A KR 960037679A
Authority
KR
South Korea
Prior art keywords
compound
formula
sodium
alkyl
represents hydrogen
Prior art date
Application number
KR1019950009470A
Other languages
English (en)
Other versions
KR100331609B1 (ko
Inventor
류성렬
Original Assignee
류성렬
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 류성렬 filed Critical 류성렬
Priority to KR1019950009470A priority Critical patent/KR100331609B1/ko
Publication of KR960037679A publication Critical patent/KR960037679A/ko
Application granted granted Critical
Publication of KR100331609B1 publication Critical patent/KR100331609B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16—Radicals substituted by halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

본 발명은 항진균제로 유용한 하기 일반식(Ⅰ)의 신규한 시스-튜불라졸 유도체에 관한 것이다 :
상기 식에서, R은 1,3-이미다졸 또는 1,2,4-트리아졸을 나타내고 ; R1는 수소 또는 C1-3알킬을 나타낸다.
본 발명은 또한 상기 정의된 일반식(Ⅰ)의 화합물을 제조하는 방법에 관한 것이다.

Description

신규한 시스-튜불라졸 유도체 및 그의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (11)

  1. 하기 일반식(Ⅰ)의 화합물, 약제학적으로 허용되는 그의 염 및 그의 입체화학적 이성체 :
    상기 식에서, R은 1,3-이미다졸 또는 1,2,4-트리아졸을 나타내고 ; R1는 수소 또는 C1-3알킬을 나타낸다.
  2. 제1항에 있어서, R1이 수소 또는 에틸을 나타내는 화합물.
  3. 하기 일반식(Ⅱ)의 화합물을 용매중에서 염기 존재하에 하기 일반식(Ⅲ)의 화합물과 반응시켜 일반식(Ⅰ)의 화합물을 제조하는 방법.
    상기 식에서, R은 1,3-이미다졸 또는 1,2,4-트리아졸을 나타내고 ; R1은 수소 또는 C1-3알킬을 나타낸다.
  4. 제3항에 있어서, 일반식(Ⅱ)의 화합물에 대한 일반식(Ⅲ)의 화합물을 0.5 내지 1.5당량배 사용하는 방법.
  5. 제3항에 있어서, 반응용매가 디메틸포름아미드, 메탄올, 에탄올, 2-에톡시에탄올, 디메틸아세트아미드, 아세토니트릴, 디메틸설폭시드, 디에틸아닐린, 이소프로필알콜 중에서 선택된 1종 이상인 방법.
  6. 제3항에 있어서, 염기가 탄산칼륨, 메톡시나트륨, 에톡시나트륨, 수산화나트륨, 수소화나트륨, 트리에틸아민, 요오드화칼륨, 피리딘, 산화마그네슘 중에서 선택된 1종 이상인 방법.
  7. 제3항에 있어서, 반응이 40 내지 120℃ 온도범위에서 수행됨을 특징으로 하는 방법.
  8. 제3항에 있어서, 추가로 R1이 C1-3알킬인 일반식(Ⅰ)의 화합물을 산 또는 알칼리 존재하에 가수분해시켜 R1이 수소인 일반식(Ⅰ)의 화합물을 제조하는 방법.
  9. 제8항에 있어서, 산이 트리플루오로아세트산인 방법.
  10. 제8항에 있어서, 알칼리가 수산화나트륨 또는 수산화칼륨인 방법.
  11. 제10항에 있어서, 알칼리 농도가 0.2 내지 1.5N인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019950009470A 1995-04-21 1995-04-21 신규한시스-튜불라졸유도체및그의제조방법 KR100331609B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950009470A KR100331609B1 (ko) 1995-04-21 1995-04-21 신규한시스-튜불라졸유도체및그의제조방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950009470A KR100331609B1 (ko) 1995-04-21 1995-04-21 신규한시스-튜불라졸유도체및그의제조방법

Publications (2)

Publication Number Publication Date
KR960037679A true KR960037679A (ko) 1996-11-19
KR100331609B1 KR100331609B1 (ko) 2002-11-18

Family

ID=37479356

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950009470A KR100331609B1 (ko) 1995-04-21 1995-04-21 신규한시스-튜불라졸유도체및그의제조방법

Country Status (1)

Country Link
KR (1) KR100331609B1 (ko)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60252480A (ja) * 1984-05-28 1985-12-13 Dainippon Pharmaceut Co Ltd イミダゾ−ル誘導体及びその塩
DK354185A (da) * 1984-08-31 1986-03-01 Hoffmann La Roche 1,3-dioxolanderivater
DE3609596A1 (de) * 1986-03-21 1987-10-01 Hoechst Ag 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
US4940799A (en) * 1987-07-20 1990-07-10 Ciba-Geigy Corporation Preparation of the diastereomeric mixture 2R,4S-1-[2-(2,4-dichlorophenyl)-4-n-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole
US5158949A (en) * 1990-12-20 1992-10-27 Syntex (U.S.A.) Inc. 1,3-dioxolane derivatives as cholesterol-lowering agents

Also Published As

Publication number Publication date
KR100331609B1 (ko) 2002-11-18

Similar Documents

Publication Publication Date Title
KR880000433A (ko) 이미다조피리딘 및 중간체 화합물의 제조방법
KR860003215A (ko) 4-페닐피롤 유도체의 제조방법
KR860008976A (ko) 2-(4-벤조일-1- 피페리딜)-1- 페닐알칸올 유도체
KR850007586A (ko) 피롤리돈 유도체의 제조방법
KR870004027A (ko) 디하이드로리제르그산의 n-알킬화 방법
KR960037679A (ko) 신규한 시스-튜불라졸 유도체 및 그의 제조방법
KR860008135A (ko) 아미노케톤 유도체의 제조방법
KR910016736A (ko) 피페라지닐 퀴놀론 유도체의 제조방법
KR850001738A (ko) 측쇄기로서 니트로메틸렌기를 갖는 헤테로고리 화합물을 제조하는 방법
DK0613896T3 (da) Fremgangsmåde til fremstilling af sulfonylurinstofderivater
KR880009919A (ko) 시아노구아니딘 유도체 및 그 제조법
KR850008160A (ko) 이미다졸 유도체의 제조방법
KR930007905A (ko) 알킬 n-(히드록시알킬)-카바메이트의 제조방법
KR930019635A (ko) 3-히드록시메틸-1-프로파르길이미다졸리딘-2,4-디온의 제조방법
KR950014105A (ko) 아졸 유도체의 제조방법
KR860000283A (ko) 피리딘 유도체의 제조방법
KR940014349A (ko) 신규 6-아미노 피리미딘-4- 티온 유도체 및 이의 제조방법
KR940014300A (ko) 2,5-디메톡시-4-할로아닐린의 제조방법
KR920012048A (ko) 퀴녹살리닐옥시페녹시프로피온산의 광학적 활성 에스테르의 제조방법
KR890003744A (ko) 아졸 유도체의 제조방법
KR890016005A (ko) 알라닌 유도체의 제조방법
KR940014327A (ko) 프롤린유도체의 제조방법
KR890003723A (ko) 1,5- 벤조티아제핀 유도체 제조방법
KR880000396A (ko) 2-(N-벤질-N-메틸아미노)에틸메틸 2,6-디메틸-4-(m-니트로페닐)-1,4-디히드로피리딘-3,5-디카르복실레이트 및 그의 염산염의 제조방법
KR930021618A (ko) 2-아미노-5-메틸-피리딘의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120323

Year of fee payment: 11

LAPS Lapse due to unpaid annual fee